Reduction of circulating β2-microglobulin level for the treatment of dialysis-related amyloidosis

Nephrology Dialysis Transplantation

Volumn 16, Issue SUPPL. 4, 2001, Pages 31-35

  Kazama, J J ^a   Maruyama, H ^a   Gejyo, F ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; BETA 2 MICROGLOBULIN; UREMIC TOXIN;

ABSORPTION; AMYLOIDOSIS; ARTHRALGIA; ARTICLE; ARTICULAR CARTILAGE; BINDING AFFINITY; BONE LESION; CIRCULATION; CLINICAL PRACTICE; CLINICAL TRIAL; DAILY LIFE ACTIVITY; DEVICE; DIALYSIS; ECONOMIC ASPECT; EXTRACORPOREAL CIRCULATION; HEMOPERFUSION; HUMAN; JOINT STIFFNESS; LONG TERM CARE; MULTICENTER STUDY; PATHOGENESIS; PLASMA CLEARANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BINDING; SYMPTOM; BLOOD; INSTRUMENTATION; METABOLISM; METHODOLOGY; RENAL REPLACEMENT THERAPY; REVIEW; TREATMENT OUTCOME;

ABSORPTION; AMYLOIDOSIS; BETA 2-MICROGLOBULIN; HUMANS; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 0034961564     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.suppl_4.31     Document Type: Article

References (33)

1. Beta-2-microglobulin-associated amyloidosis
2. A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin
3. Megalin is an endocytic receptor for insulin
4. Long-term complications of dialysis: Pathogenic factors with special reference to amyloidosis
5. In vitro formation of amyloid fibrils from intact beta 2-microglobulin
6. First-order kinetic model of Alzheimer's beta-amyloid fibril extension in vitro
7. Modification of beta 2-microglobulin with D-glucose or 3-deoxyglucosone inhibits a beta 2M amyloid fibril extension in vitro
8. Monomeric and dimeric beta 2-microglobulin may be extracted from amyloid deposits in vitro
9. Role of macrophages in beta 2-microglobulin-related dialysis amyloidosis
10. Effect of renal transplantation on the radiological signs of dialysis amyloid osteoarthropathy
11. Dialysis-related beta-2-microglobulin amyloidosis after long-term dialysis and the effect of renal transplantation and cyclosporin therapy
12. Renal transplantation relieves the symptoms but does not reverse beta 2-microglobulin amyloidosis
13. Long term effect of renal transplantation on dialysis-related amyloid deposits and symptomatology
14. Histological beta-2-microglobulin amyloidosis 10 years after a successful renal transplantation
15. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor factor-alpha and interleukin-1
16. Learning from the Japanese Registry: How will we prevent long-term complications?
17. Beta 2-microglobulin elimination in end-stage renal disease patients on renal replacement therapy
18. Different handling of beta 2-microglobulin during hemodialysis and hemofiltration
19. Effects of dialysis membranes on beta 2-microglobulin production and cellular expression
20. Effects of hemodialysis on activation of lymphocytes: Analysis by an in vitro dialysis model
21. The effect of membrane biocompatibility on plasma beta 2-microglobulin levels in chronic hemodialysis patients
22. Beta 2-microglobulin kinetics in maintenance hemodialysis: A comparison of conventional and high-flux dialyzers and the effects of dialyzer reuse
23. Influence of dialysis membranes on the development of dialysis associated osteoarthropathy
24. The effects of the dialysis membrane on cytokine release
25. Cuprophane but not synthetic membrane induces increases in serum tumor necrosis factor-alpha levels during hemodialysis
26. Clinical and pathogenic factors in dialysis-related amyloidosis: Current research findings
27. A new treatment for dialysis-related amyloidosis with beta 2-microglobulin adsorbent column
28. A new therapeutic approach to dialysis amyloidosis: Intensive removal of beta 2-microglobulin with adsorbent column
29. Long-term clinical evaluation of an adsorbent column (BM-01) of direct hemoperfusion type for beta 2-microglobulin on the treatment of dialysis-related amyloidosis
30. Remission of a recurrent carpal tunnel syndrome by a new device of the hemodialysis method in a long-term hemodialysis patient
31. Dialysis related amyloidosis: A disease of chronic retention and inflammation?
32. 131I-beta 2-microglobulin in patients with dialysis related amyloidosis
33. 131I-β2-microglobulin scintigraphy in patients with dialysis amyloidosis